BioSpace News Archive

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its 2019 financial and operating results on Thursday, March 12, 2020, after the close of the U.S. financial markets.

Annual gathering of leading oncology professionals to discuss latest cancer research and guidelines postponed out of concern for vulnerable populations.

Kinnos, an infection prevention company transforming patient safety and hospital efficiency, announces that it has closed a new $6 million investment round. Known for pioneering colorized disinfection, Kinnos will use the funding to accelerate its growth and new product development

Products become the first and only indicated to reduce blood culture contamination

Aya Healthcare, the only tech-enabled healthcare staffing company with scale, has launched end-to-end mobile capabilities, enabling healthcare facilities and clinicians to digitally communicate on-the-go.

Molecular diagnostics company XCR Diagnostics has been awarded a patent by the United States Patent and Trademark Office for its technology that speeds up the testing and identification process for infectious diseases.

AccuReg, a healthcare technology solutions company offering a full suite of front-end revenue cycle management solutions for hospitals, announces Blair Baker has joined the company as chief information officer and chief product officer.

A new academic analysis, “Independent Pharmacies in the U.S. are More on the Rise than on the Decline,” sets the record straight on the health of independent pharmacies in the U.S. by showing the overall number of stores has increased by 2,600 over the last decade, approximately a 13 percent increase.

Supira Medical, formed by Shifamed as part of its medical innovation hub, announced today the closing of $35M in Series B financing. Officially closed on February 25, the financing was led by Cormorant Asset Management with participation from The Capital Partnership (TCP), 415 CAPITAL, AMED Ventures and Shifamed Angels.

Cantel Medical Corp. (NYSE: CMD) today announced financial results for its second quarter ended January 31, 2020.